跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BAPIRI 0,3 MG + 5 MG/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BAPIRI 0,3 MG + 5 MG/ML COLIRIO EN SOLUCION
Approved
STANDARD
BAPIRI 0,3 MG + 5 MG/ML COLIRIO EN SOLUCION
Brill Pharma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 5, 2021
Approval ID
457d08262a5e4261
Company
Brill Pharma S.L.
Type
Standard
Approval Details
Approval Id
457d08262a5e4261
Drug Cima Aemps Name
BAPIRI 0,3 MG + 5 MG/ML COLIRIO EN SOLUCION
Register Number
86288
Holder Company Name
Brill Pharma S.L.
Marketing Company Name
Brill Pharma S.L.
Authorization Date
2021-10-05
Dosage Form
COLIRIO EN SOLUCIÓN
Dose
0,3 mg/ml + 5 mg/ml
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Brill Pharma S.L.
Active Ingredients
BIMATOPROST
0,3 mg/ml
TIMOLOL MALEATO
6,83 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 5, 2021
Approval ID
457d08262a5e4261
Type
Standard
Back to CIMA-AEMPS Approvals
